Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling

Journal of Human Hypertension volume 32, pages 12–19 (2018)Cite this article

Subjects

Abstract

Subtype diagnosis of primary aldosteronism (PA) by adrenal vein sampling (AVS) is recommended as a mandatory step for indicating adrenal surgery. It is a technically demanding procedure, especially in the right adrenal vein. The aim of the study was to predict the subtype diagnosis in the absence of values from the right AVS. From the databases of nine centers (WAVES-J), 308 patients with PA who underwent successful AVS were studied. Based on the ipsilateral ratio (IR) (aldosterone/cortisol ratio of the left adrenal vein [A/Cleft AV] / aldosterone/cortisol ratio of the inferior vena cava [A/CIVC]), the patients were divided into two groups: the patients with IR ≥ 1.0 (n = 262) and those with IR < 1.0 (n = 46). In patients with IR > 1.0, the A/Cleft AV was significantly higher in patients with the left unilateral subtype than in patients with the bilateral subtype. Receiver operating characteristic (ROC) curve analysis revealed that an A/Cleft AV cutoff >68 showed 70.8% sensitivity and 93.5% specificity for the left unilateral subtype. On the other hand, in patients with IR < 1.0, the A/Cleft AV was significantly lower in patients with the right unilateral subtype. ROC analysis revealed that an A/Cleft AV cutoff <9 showed 86.7% sensitivity and 75.0% specificity for the right unilateral subtype. Hence, the combination of the IR and A/C ratio in the left adrenal vein is useful for predicting the subtype. The present results provide important information for patients with PA in whom AVS was unsuccessful in the right adrenal vein.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293–300.

    Article  CAS  Google Scholar 

  2. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85:1863–7.

    CAS  PubMed  Google Scholar 

  3. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295:2638–45.

    Article  CAS  Google Scholar 

  4. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50:911–8.

    Article  CAS  Google Scholar 

  5. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243–8.

    Article  CAS  Google Scholar 

  6. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol. 2007;66:607–18.

    Article  CAS  Google Scholar 

  7. Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19:353–61.

    Article  CAS  Google Scholar 

  8. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266–81.

    Article  CAS  Google Scholar 

  9. Rossi GP, Barisa M, Allolio B, Auchus RJ, Amar L, Cohen D, et al. The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2012;97:1606–14.

    Article  CAS  Google Scholar 

  10. Vonend O, Ockenfels N, Gao X, Allolio B, Lang K, Mai K, et al. Adrenal venous sampling: evaluation of the German Conn’s registry. Hypertension. 2011;57:990–5.

    Article  CAS  Google Scholar 

  11. Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151–60.

    Article  CAS  Google Scholar 

  12. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:1227–35.

    Article  Google Scholar 

  13. Stowasser M, Gordon RD, Rutherford JC, Nikwan NZ, Daunt N, Slater GJ. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2001;2:156–69.

    Article  CAS  Google Scholar 

  14. Umakoshi H, Wada N, Ichijo T, Kamemura K, Matsuda Y, Fuji Y, et al. Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism. Clin Endocrinol. 2015;83:768–73.

    Article  CAS  Google Scholar 

  15. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, et al. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr J. 2011;58:711–21.

    Article  CAS  Google Scholar 

  16. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.

    Article  Google Scholar 

  17. Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens. 2008;26:989–97.

    Article  CAS  Google Scholar 

  18. Young WF Jr, Klee GG. Primary aldosteronism. Diagnostic evaluation. Endocrinol Metab Clin North Am. 1988;17:367–95.

    Article  Google Scholar 

  19. Daunt N. Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics. 2005;25(Suppl 1):S143–58.

    Article  Google Scholar 

  20. Davidson JK, Morley P, Hurley GD, Holford NG. Adrenal venography and ultrasound in the investigation of the adrenal gland: an analysis of 58 cases. Br J Radiol. 1975;48:435–50.

    Article  CAS  Google Scholar 

  21. Auchus RJ, Michaelis C, Wians FH Jr, Dolmatch BL, Josephs SC, Trimmer CK, et al. Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann Surg. 2009;249:318–21.

    Article  Google Scholar 

  22. Young WF, Stanson AW. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol. 2009;70:14–7.

    Article  Google Scholar 

  23. Mulatero P, Bertello C, Sukor N, Gordon R, Rossato D, Daunt N, et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension. 2010;55:667–73.

    Article  CAS  Google Scholar 

  24. Kline GA, Pasieka JL, Harvey A, So B, Dias VC. A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism. J Hum Hypertens. 2014;28:298–302.

    Article  CAS  Google Scholar 

  25. Young WF Jr, Stanson AW, Grant CS, Thompson GB, van Heerden JA. Primary aldosteronism: adrenal venous sampling. Surgery. 1996;120:913–9. discussion 919–20.

    Article  Google Scholar 

  26. Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ. Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab. 2003;88:3637–44.

    Article  CAS  Google Scholar 

  27. Umakoshi H, Naruse M, Wada N, Ichijo T, Kamemura K, Matsuda Y, et al. Adrenal venous sampling in patients with positive screening but negative confirmatory testing for primary aldosteronism. Hypertension. 2016;67:1014–9.

    Article  CAS  Google Scholar 

  28. Monticone S, Satoh F, Viola A, Fischer E, Vonend O, Bernini G, et al. Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. J Clin Endocrinol Metab.2014;99:4158–66. https://doi.org/10.1210/jc2014-2345.

    Article  CAS  PubMed  Google Scholar 

  29. Wolley MJ, Gordon RD, Ahmed AH, Stowasser M. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Clin Endocrinol Metab. 2015;100:1477–84.

    Article  CAS  Google Scholar 

  30. Wolley M, Gordon RD, Pimenta E, Daunt N, Slater GJ, Ahmed AH, et al. Repeating adrenal vein sampling when neither aldosterone/cortisol ratio exceeds peripheral yields a high incidence of aldosterone-producing adenoma. J Hypertens. 2013;31:2005–9.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported, in part, by grants-in-aid for the study of primary aldosteronism in Japan (JPAS) from The Practical Research Project for Rare/Intractable Disease from the Japan Agency for Medical Research and Development (AMED) (15Aek0509122) and a Grant from the National Center for Global Health and Medicine, Japan (24-1402).

Author information

Authors and Affiliations

  1. Department of Cardiology, JR Hiroshima Hospital, Hiroshima, Japan

    Yuichi Fujii

  2. Department of Endocrinology, Metabolism, and Hypertension, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

    Hironobu Umakoshi, Kazutaka Nanba, Mika Tsuiki & Mitsuhide Naruse

  3. Department of Diabetes and Endocrinology, Sapporo City Hospital, Sapporo, Japan

    Norio Wada

  4. Department of Diabetes and Endocrinology, Saiseikai Yokohama City Toubu Hospital, Yokohama, Japan

    Takamasa Ichijo

  5. Department of Cardiology, Akashi Medical Center, Akashi, Japan

    Kohei Kamemura

  6. Department of Cardiology, Sanda City Hospital, Sanda, Japan

    Yuichi Matsuda

  7. Department of Cardiology, Saiseikai Tondabayashi Hospital, Osaka, Japan

    Tatsuya Kai

  8. Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan

    Tomikazu Fukuoka

  9. Department of Endocrinology and Metabolism, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

    Ryuichi Sakamoto & Atsushi Ogo

  10. Department of Public Health,School of Medicine, International University of Health and Welfare, Narita, Japan

    Tomoko Suzuki

Authors
  1. Yuichi Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hironobu Umakoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Norio Wada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takamasa Ichijo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kohei Kamemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuichi Matsuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tatsuya Kai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tomikazu Fukuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ryuichi Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Atsushi Ogo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tomoko Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kazutaka Nanba
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Mika Tsuiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Mitsuhide Naruse
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of WAVES-J Study Group

Corresponding author

Correspondence to Yuichi Fujii.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujii, Y., Umakoshi, H., Wada, N. et al. Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling. J Hum Hypertens 32, 12–19 (2018). https://doi.org/10.1038/s41371-017-0015-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-017-0015-0

This article is cited by

Search

Advanced search

Quick links